Mpox vaccine triggers equally strong immune response with smaller doses in people with or without HIV, finds study

by

Delivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune response, a new study shows. This also occurred regardless of whether people were living with or without HIV.

Leave A Comment

Your email address will not be published. Required fields are marked *